Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations-Reference-Cited by-同舟云学术

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations

Published:2017-02-01 Issue:2 Volume:74 Page:216
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Schapira Anthony H. V.¹,Fox Susan H.²,Hauser Robert A.³,Jankovic Joseph⁴,Jost Wolfgang H.⁵,Kenney Christopher⁶,Kulisevsky Jaime⁷,Pahwa Rajesh⁸,Poewe Werner⁹,Anand Ravi¹⁰

Affiliation:

1. Department of Clinical Neurosciences, University College London Institute of Neurology, London, United Kingdom

2. Department of Medicine, Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada

3. Department of Neurology, University of South Florida College of Medicine, Tampa

4. Department of Neurology, Baylor College of Medicine, Houston, Texas

5. Parkinson-Klinik, Wolfach, Germany

6. Biotie Therapies Inc, San Francisco, California

7. Servicio de Neurología, Sant Pau Hospital, Universidad Autonoma de Barcelona, Universitat Oberta de Catalunya, Barcelona, Spain

8. Department of Neurology, University of Kansas Medical Center, Kansas City

9. Department of Neurology, Medical University Innsbruck, Innsbruck, Austria

10. APC, St Moritz, Switzerland

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parkinson’s Disease;International Encyclopedia of Public Health;2025

2. Monoamine oxidase and neurodegeneration: Mechanisms, inhibitors and natural compounds for therapeutic intervention;Neurochemistry International;2024-10

3. Factors associated with a placebo effect in Parkinson’s disease in clinical trials: a meta-analysis;Journal of Neurology;2024-07-02

4. Response to letter to editor ‘comment on: Safinamide as adjunctive therapy for Parkinson's disease: A promising option with room for improvement’;Journal of the Neurological Sciences;2024-07

5. Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER study;Journal of the Neurological Sciences;2024-06